Oligodendrocyte-Specific STAT5B Overexpression Ameliorates Myelin Impairment in Experimental Models of Parkinson’s Disease
Cells · 2025
DOI: 10.3390/cells14151145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Yibo Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Anatomy, Hebei Medical University, Shijiazhuang 050017, China. Hauptthemen laut MEDLINE: Myelin Sheath, STAT5 Transcription Factor, Oligodendroglia, Parkinson Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hebei Province, Hebei Province Medical Science Research Projects.
Abstract (Originalsprache)
Background
Parkinson’s disease (PD) involves progressive dopaminergic neuron degeneration and motor deficits. Oligodendrocyte dysfunction contributes to PD pathogenesis through impaired myelination.
Methods
Single-nucleus RNA sequencing (snRNA-seq) of PD mice revealed compromised oligodendrocyte differentiation and STAT5B downregulation. Pseudotemporal trajectory analysis via Monocle2 demonstrated impaired oligodendrocyte maturation in PD oligodendrocytes, correlating with reduced myelin-related gene expression (Sox10, Plp1, Mbp, Mog, Mag, Mobp). DoRothEA-predicted regulon activity identified STAT5B as a key transcriptional regulator.
Results
Oligodendrocyte-specific STAT5B activation improved myelin integrity, as validated by Luxol Fast Blue staining and transmission electron microscopy; attenuated dopaminergic neuron loss; and improved motor function. Mechanistically, STAT5B binds the MBP promoter to drive transcription, a finding confirmed by the luciferase assay, while the DNMT3A-mediated hypermethylation of the STAT5B promoter epigenetically silences its expression, as verified by MethylTarget sequencing and methylation-specific PCR.
Conclusions
DNMT3A inhibited the expression of STAT5B by affecting its methylation, which reduced the transcription of MBP, caused oligodendrocyte myelin damage, and eventually led to dopamine neuron damage and motor dysfunction in an MPTP-induced mouse model. This DNMT3A-STAT5B-MBP axis underlies PD-associated myelin damage, connecting epigenetic dysregulation with oligodendrocyte dysfunction and subsequent PD pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Anatomy, Hebei Medical University, Shijiazhuang 050017, China.
- The Key Laboratory of Neural and Vascular Biology, Ministry of Education, Hebei Medical University, Shijiazhuang 050017, China.
- Neuroscience Research Center, Hebei Medical University, Shijiazhuang 050017, China.
- Hebei Key Laboratory of Neurodegenerative Disease Mechanism, Shijiazhuang 050017, China.
ORCID-Profile: Qing Liu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hebei Province
- Hebei Province Medical Science Research Projects
- The Key Laboratory of Neural and Vascular Biology, Ministry of Education
- Key Laboratory of Neural and Vascular Biology, Ministry of Education
Zitieren
APA
Li, Y., Su, Z., Zhai, J., Liu, Q., Wang, H., Hao, J., Tian, X., Gao, J., Geng, D., & Wang, L. (2025). Oligodendrocyte-Specific STAT5B Overexpression Ameliorates Myelin Impairment in Experimental Models of Parkinson’s Disease. Cells. https://doi.org/10.3390/cells14151145
Vancouver
Li Y, Su Z, Zhai J, Liu Q, Wang H, Hao J, et al. Oligodendrocyte-Specific STAT5B Overexpression Ameliorates Myelin Impairment in Experimental Models of Parkinson’s Disease. Cells. 2025. doi:10.3390/cells14151145
BibTeX
@article{Li2025,
author = {Li, Yibo and Su, Zhaowen and Zhai, Jitong and Liu, Qing and Wang, Hongfang and Hao, Jiaxin and Tian, Xiaofeng and Gao, Jiamin and Geng, Dandan and Wang, Lei},
title = {Oligodendrocyte-Specific STAT5B Overexpression Ameliorates Myelin Impairment in Experimental Models of Parkinson’s Disease},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14151145}
}
EUVIMED